Yuri Agrawal
Concepts (318)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vestibular Diseases | 28 | 2025 | 54 | 9.640 |
Why?
| | Vestibule, Labyrinth | 18 | 2025 | 91 | 5.910 |
Why?
| | Postural Balance | 18 | 2026 | 246 | 4.530 |
Why?
| | Aging | 27 | 2025 | 1972 | 4.270 |
Why?
| | Accidental Falls | 18 | 2025 | 228 | 3.950 |
Why?
| | Reflex, Vestibulo-Ocular | 14 | 2022 | 31 | 3.940 |
Why?
| | Vertigo | 14 | 2024 | 53 | 3.710 |
Why?
| | Vestibular Evoked Myogenic Potentials | 14 | 2025 | 18 | 3.570 |
Why?
| | Alzheimer Disease | 9 | 2023 | 616 | 3.220 |
Why?
| | Vestibular Function Tests | 21 | 2025 | 41 | 3.100 |
Why?
| | Spatial Navigation | 5 | 2024 | 18 | 2.770 |
Why?
| | Cognitive Dysfunction | 8 | 2024 | 454 | 2.580 |
Why?
| | Saccule and Utricle | 6 | 2024 | 13 | 2.100 |
Why?
| | Semicircular Canals | 9 | 2020 | 33 | 2.030 |
Why?
| | Dizziness | 11 | 2023 | 94 | 1.990 |
Why?
| | Hearing Loss | 11 | 2024 | 244 | 1.980 |
Why?
| | Cross-Sectional Studies | 39 | 2025 | 5776 | 1.800 |
Why?
| | Longitudinal Studies | 27 | 2025 | 2955 | 1.740 |
Why?
| | Head Movements | 8 | 2022 | 36 | 1.570 |
Why?
| | Virtual Reality | 3 | 2024 | 76 | 1.500 |
Why?
| | Aged | 67 | 2026 | 25675 | 1.480 |
Why?
| | Aged, 80 and over | 35 | 2026 | 8154 | 1.480 |
Why?
| | Vision Disorders | 7 | 2026 | 175 | 1.470 |
Why?
| | Physical Therapy Modalities | 3 | 2021 | 329 | 1.290 |
Why?
| | Otologic Surgical Procedures | 8 | 2016 | 22 | 1.280 |
Why?
| | Baltimore | 11 | 2024 | 67 | 1.250 |
Why?
| | Gait | 5 | 2022 | 324 | 1.240 |
Why?
| | Head Impulse Test | 8 | 2019 | 9 | 1.240 |
Why?
| | Cognition Disorders | 3 | 2019 | 542 | 1.110 |
Why?
| | Eye Movements | 5 | 2015 | 92 | 1.040 |
Why?
| | Humans | 115 | 2026 | 144228 | 1.030 |
Why?
| | Ear, Inner | 2 | 2025 | 52 | 0.960 |
Why?
| | Neuroma, Acoustic | 5 | 2014 | 54 | 0.960 |
Why?
| | Male | 75 | 2026 | 71757 | 0.940 |
Why?
| | Sensorimotor Cortex | 1 | 2025 | 8 | 0.910 |
Why?
| | Female | 76 | 2026 | 77795 | 0.910 |
Why?
| | Middle Aged | 52 | 2025 | 35731 | 0.910 |
Why?
| | Independent Living | 4 | 2026 | 113 | 0.900 |
Why?
| | Entorhinal Cortex | 1 | 2025 | 15 | 0.890 |
Why?
| | Frontal Lobe | 1 | 2025 | 159 | 0.830 |
Why?
| | Health Surveys | 8 | 2018 | 510 | 0.820 |
Why?
| | Meniere Disease | 3 | 2014 | 35 | 0.820 |
Why?
| | Telerehabilitation | 1 | 2024 | 43 | 0.810 |
Why?
| | Prevalence | 15 | 2022 | 2820 | 0.810 |
Why?
| | Neurotology | 3 | 2018 | 5 | 0.760 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 327 | 0.720 |
Why?
| | Nutrition Surveys | 7 | 2021 | 279 | 0.690 |
Why?
| | Walking Speed | 2 | 2022 | 52 | 0.690 |
Why?
| | Orientation, Spatial | 1 | 2021 | 11 | 0.660 |
Why?
| | Adult | 43 | 2024 | 40230 | 0.660 |
Why?
| | Healthy Aging | 1 | 2021 | 37 | 0.650 |
Why?
| | Saccades | 3 | 2017 | 45 | 0.640 |
Why?
| | Sensation Disorders | 3 | 2026 | 41 | 0.630 |
Why?
| | Surveys and Questionnaires | 9 | 2023 | 6031 | 0.600 |
Why?
| | Proprioception | 1 | 2019 | 34 | 0.570 |
Why?
| | Space Perception | 2 | 2018 | 83 | 0.560 |
Why?
| | Bilateral Vestibulopathy | 1 | 2018 | 1 | 0.550 |
Why?
| | United States | 23 | 2026 | 15641 | 0.540 |
Why?
| | Bone Conduction | 3 | 2014 | 24 | 0.530 |
Why?
| | Otolithic Membrane | 2 | 2019 | 7 | 0.520 |
Why?
| | Accidents, Traffic | 1 | 2018 | 190 | 0.510 |
Why?
| | Developmental Disabilities | 1 | 2019 | 294 | 0.490 |
Why?
| | Activities of Daily Living | 3 | 2016 | 435 | 0.490 |
Why?
| | Risk Factors | 15 | 2026 | 10641 | 0.480 |
Why?
| | Social Participation | 1 | 2016 | 29 | 0.480 |
Why?
| | Frailty | 3 | 2025 | 190 | 0.480 |
Why?
| | Automobile Driving | 1 | 2018 | 154 | 0.460 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 424 | 0.450 |
Why?
| | Referral and Consultation | 1 | 2021 | 841 | 0.440 |
Why?
| | Psychotropic Drugs | 1 | 2015 | 76 | 0.430 |
Why?
| | Self Report | 2 | 2021 | 867 | 0.430 |
Why?
| | Hearing | 3 | 2023 | 130 | 0.430 |
Why?
| | Eye Movement Measurements | 1 | 2014 | 14 | 0.420 |
Why?
| | Hearing Loss, Noise-Induced | 2 | 2012 | 18 | 0.410 |
Why?
| | Reaction Time | 2 | 2015 | 441 | 0.410 |
Why?
| | Auditory Threshold | 3 | 2012 | 50 | 0.410 |
Why?
| | Prospective Studies | 9 | 2023 | 7911 | 0.400 |
Why?
| | Walking | 5 | 2022 | 561 | 0.400 |
Why?
| | Visual Perception | 1 | 2015 | 183 | 0.390 |
Why?
| | Turner Syndrome | 1 | 2014 | 65 | 0.390 |
Why?
| | Petrous Bone | 1 | 2012 | 8 | 0.390 |
Why?
| | Bone Cysts | 1 | 2012 | 11 | 0.380 |
Why?
| | Sleep Wake Disorders | 1 | 2017 | 312 | 0.380 |
Why?
| | Olfaction Disorders | 2 | 2023 | 70 | 0.370 |
Why?
| | Hippocampus | 1 | 2018 | 968 | 0.370 |
Why?
| | Bone Density | 1 | 2016 | 501 | 0.370 |
Why?
| | Health Status Disparities | 1 | 2016 | 317 | 0.370 |
Why?
| | Ear Canal | 1 | 2012 | 15 | 0.360 |
Why?
| | Mouth Diseases | 2 | 2009 | 46 | 0.350 |
Why?
| | Point-of-Care Systems | 1 | 2014 | 187 | 0.350 |
Why?
| | Dementia | 2 | 2026 | 298 | 0.350 |
Why?
| | Hypersensitivity | 1 | 2014 | 265 | 0.340 |
Why?
| | Ear Neoplasms | 1 | 2010 | 10 | 0.330 |
Why?
| | Tinnitus | 3 | 2022 | 66 | 0.320 |
Why?
| | Cohort Studies | 9 | 2024 | 5876 | 0.320 |
Why?
| | Body Weight | 1 | 2015 | 993 | 0.320 |
Why?
| | Mobility Limitation | 3 | 2022 | 66 | 0.320 |
Why?
| | Noise, Occupational | 1 | 2010 | 4 | 0.320 |
Why?
| | Electronic Health Records | 1 | 2018 | 1171 | 0.320 |
Why?
| | Odds Ratio | 5 | 2016 | 1057 | 0.310 |
Why?
| | Audiometry | 4 | 2012 | 33 | 0.310 |
Why?
| | Frail Elderly | 3 | 2025 | 131 | 0.310 |
Why?
| | Cardiovascular Diseases | 4 | 2015 | 2101 | 0.300 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 572 | 0.300 |
Why?
| | Socioeconomic Factors | 4 | 2017 | 1327 | 0.300 |
Why?
| | Diabetes Complications | 1 | 2010 | 227 | 0.290 |
Why?
| | Logistic Models | 5 | 2019 | 2096 | 0.290 |
Why?
| | Human papillomavirus 16 | 1 | 2008 | 31 | 0.280 |
Why?
| | Regression Analysis | 3 | 2017 | 1003 | 0.280 |
Why?
| | Cognition | 4 | 2023 | 1255 | 0.280 |
Why?
| | Smell | 3 | 2023 | 132 | 0.270 |
Why?
| | Magnetic Resonance Imaging | 5 | 2025 | 3842 | 0.270 |
Why?
| | Papillomavirus Infections | 2 | 2009 | 354 | 0.260 |
Why?
| | Severity of Illness Index | 2 | 2014 | 2930 | 0.260 |
Why?
| | Cytotoxins | 1 | 2006 | 16 | 0.240 |
Why?
| | Azathioprine | 1 | 2006 | 48 | 0.240 |
Why?
| | Multivariate Analysis | 5 | 2024 | 1509 | 0.240 |
Why?
| | Mental Disorders | 1 | 2015 | 1129 | 0.240 |
Why?
| | Medicare | 2 | 2026 | 823 | 0.230 |
Why?
| | Laryngeal Diseases | 1 | 2006 | 32 | 0.230 |
Why?
| | Rotation | 3 | 2015 | 120 | 0.230 |
Why?
| | Neuropsychological Tests | 3 | 2023 | 1125 | 0.230 |
Why?
| | Risk | 3 | 2015 | 902 | 0.220 |
Why?
| | Population Surveillance | 1 | 2008 | 491 | 0.220 |
Why?
| | Postoperative Period | 4 | 2016 | 353 | 0.220 |
Why?
| | Temporal Bone | 2 | 2016 | 42 | 0.210 |
Why?
| | Head and Neck Neoplasms | 2 | 2009 | 560 | 0.210 |
Why?
| | Incidence | 5 | 2026 | 2852 | 0.210 |
Why?
| | International Classification of Diseases | 1 | 2025 | 140 | 0.200 |
Why?
| | Sarcoidosis | 1 | 2006 | 160 | 0.200 |
Why?
| | Retrospective Studies | 11 | 2024 | 16805 | 0.200 |
Why?
| | Treatment Outcome | 9 | 2018 | 11501 | 0.200 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 647 | 0.200 |
Why?
| | Visual Acuity | 4 | 2021 | 486 | 0.200 |
Why?
| | Geriatric Assessment | 3 | 2025 | 229 | 0.200 |
Why?
| | Young Adult | 11 | 2024 | 13949 | 0.190 |
Why?
| | Adolescent | 10 | 2024 | 22282 | 0.190 |
Why?
| | Mastoiditis | 1 | 2022 | 10 | 0.190 |
Why?
| | Bullying | 1 | 2023 | 45 | 0.180 |
Why?
| | Cerebellopontine Angle | 2 | 2012 | 8 | 0.180 |
Why?
| | Disability Evaluation | 2 | 2016 | 308 | 0.180 |
Why?
| | White Matter | 1 | 2024 | 151 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.180 |
Why?
| | Neurodegenerative Diseases | 1 | 2024 | 146 | 0.180 |
Why?
| | Hearing Loss, Sudden | 1 | 2021 | 7 | 0.170 |
Why?
| | Reference Values | 2 | 2014 | 807 | 0.170 |
Why?
| | Immunosuppressive Agents | 1 | 2006 | 844 | 0.170 |
Why?
| | Exercise Therapy | 1 | 2025 | 469 | 0.170 |
Why?
| | Risk Assessment | 6 | 2018 | 3560 | 0.170 |
Why?
| | Motion Perception | 1 | 2021 | 20 | 0.170 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2021 | 80 | 0.170 |
Why?
| | Crime Victims | 1 | 2023 | 130 | 0.160 |
Why?
| | Ear Diseases | 2 | 2018 | 17 | 0.160 |
Why?
| | Anesthesiology | 1 | 2023 | 171 | 0.160 |
Why?
| | Data Collection | 1 | 2023 | 635 | 0.160 |
Why?
| | Migraine Disorders | 1 | 2022 | 109 | 0.160 |
Why?
| | Neurosurgical Procedures | 2 | 2012 | 202 | 0.160 |
Why?
| | Postoperative Complications | 4 | 2016 | 2904 | 0.150 |
Why?
| | Caloric Tests | 1 | 2019 | 3 | 0.150 |
Why?
| | Environmental Exposure | 2 | 2016 | 586 | 0.140 |
Why?
| | Age Factors | 3 | 2016 | 3295 | 0.140 |
Why?
| | Healthy Volunteers | 1 | 2019 | 218 | 0.140 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 258 | 0.140 |
Why?
| | Efficiency | 1 | 2018 | 103 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2019 | 351 | 0.130 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 877 | 0.130 |
Why?
| | Labyrinth Diseases | 1 | 2016 | 8 | 0.130 |
Why?
| | Eustachian Tube | 1 | 2016 | 8 | 0.120 |
Why?
| | Otolaryngology | 1 | 2018 | 107 | 0.120 |
Why?
| | Melanins | 1 | 2016 | 17 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 4 | 2022 | 2788 | 0.120 |
Why?
| | Audiometry, Pure-Tone | 2 | 2012 | 34 | 0.120 |
Why?
| | Pigmentation | 1 | 2016 | 53 | 0.120 |
Why?
| | Marital Status | 1 | 2016 | 47 | 0.120 |
Why?
| | Immunotherapy | 1 | 2020 | 670 | 0.120 |
Why?
| | Case-Control Studies | 3 | 2019 | 3618 | 0.110 |
Why?
| | Denervation | 1 | 2015 | 27 | 0.110 |
Why?
| | Vestibular Nerve | 1 | 2015 | 19 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 2018 | 281 | 0.110 |
Why?
| | Linear Models | 1 | 2018 | 859 | 0.110 |
Why?
| | Smoke | 1 | 2016 | 152 | 0.110 |
Why?
| | Confusion | 1 | 2015 | 30 | 0.110 |
Why?
| | Interviews as Topic | 2 | 2016 | 890 | 0.110 |
Why?
| | Brain | 2 | 2024 | 2909 | 0.110 |
Why?
| | Comorbidity | 1 | 2019 | 1638 | 0.110 |
Why?
| | Environment | 1 | 2016 | 306 | 0.110 |
Why?
| | Hospital Rapid Response Team | 1 | 2014 | 21 | 0.110 |
Why?
| | Speech Perception | 2 | 2012 | 88 | 0.110 |
Why?
| | Physicians | 1 | 2023 | 933 | 0.110 |
Why?
| | Nystagmus, Pathologic | 1 | 2014 | 20 | 0.100 |
Why?
| | Memory Disorders | 1 | 2015 | 195 | 0.100 |
Why?
| | Airway Management | 1 | 2014 | 81 | 0.100 |
Why?
| | Melanoma | 1 | 2020 | 809 | 0.100 |
Why?
| | Atrophy | 2 | 2024 | 199 | 0.100 |
Why?
| | Sex Characteristics | 1 | 2019 | 786 | 0.100 |
Why?
| | Locomotion | 1 | 2014 | 103 | 0.100 |
Why?
| | Acoustic Stimulation | 1 | 2015 | 332 | 0.100 |
Why?
| | Laryngoscopy | 1 | 2014 | 122 | 0.100 |
Why?
| | Ocular Motility Disorders | 1 | 2014 | 41 | 0.100 |
Why?
| | Sickness Impact Profile | 1 | 2013 | 60 | 0.100 |
Why?
| | Refractive Errors | 1 | 2013 | 36 | 0.100 |
Why?
| | Benign Paroxysmal Positional Vertigo | 1 | 2013 | 6 | 0.100 |
Why?
| | Mucocele | 1 | 2012 | 13 | 0.100 |
Why?
| | Encephalocele | 1 | 2012 | 12 | 0.100 |
Why?
| | Carcinoma, Adenoid Cystic | 1 | 2012 | 19 | 0.090 |
Why?
| | Video Recording | 1 | 2014 | 210 | 0.090 |
Why?
| | Quality Improvement | 2 | 2018 | 1271 | 0.090 |
Why?
| | Antigens, Differentiation | 1 | 2012 | 78 | 0.090 |
Why?
| | Cranial Fossa, Middle | 1 | 2012 | 18 | 0.090 |
Why?
| | Salivary Gland Neoplasms | 1 | 2012 | 39 | 0.090 |
Why?
| | Recurrence | 1 | 2016 | 1123 | 0.090 |
Why?
| | Vocal Cord Paralysis | 1 | 2012 | 28 | 0.090 |
Why?
| | Smoking | 2 | 2010 | 1557 | 0.090 |
Why?
| | Depressive Disorder | 1 | 2015 | 368 | 0.090 |
Why?
| | Age Distribution | 2 | 2013 | 396 | 0.090 |
Why?
| | Sex Distribution | 2 | 2013 | 380 | 0.090 |
Why?
| | Anxiety Disorders | 1 | 2015 | 365 | 0.090 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 312 | 0.090 |
Why?
| | Sex Factors | 2 | 2015 | 2081 | 0.090 |
Why?
| | Proportional Hazards Models | 2 | 2026 | 1306 | 0.090 |
Why?
| | Motor Activity | 1 | 2016 | 722 | 0.080 |
Why?
| | Endolymphatic Hydrops | 1 | 2010 | 4 | 0.080 |
Why?
| | Functional Laterality | 1 | 2012 | 242 | 0.080 |
Why?
| | Respiratory Insufficiency | 1 | 2014 | 333 | 0.080 |
Why?
| | Educational Status | 1 | 2012 | 463 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3402 | 0.080 |
Why?
| | Deglutition Disorders | 1 | 2011 | 150 | 0.080 |
Why?
| | Microsurgery | 1 | 2010 | 75 | 0.080 |
Why?
| | Diabetic Neuropathies | 1 | 2010 | 97 | 0.080 |
Why?
| | Mental Health | 1 | 2016 | 778 | 0.080 |
Why?
| | Exercise | 1 | 2021 | 2198 | 0.080 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 444 | 0.080 |
Why?
| | Sleep | 1 | 2017 | 905 | 0.070 |
Why?
| | Reoperation | 1 | 2012 | 602 | 0.070 |
Why?
| | Craniotomy | 1 | 2009 | 80 | 0.070 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2009 | 55 | 0.070 |
Why?
| | Qualitative Research | 1 | 2016 | 1640 | 0.070 |
Why?
| | Noise | 1 | 2009 | 71 | 0.070 |
Why?
| | Diabetic Retinopathy | 1 | 2010 | 206 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1758 | 0.070 |
Why?
| | DNA Methylation | 1 | 2012 | 676 | 0.070 |
Why?
| | Patient Satisfaction | 1 | 2012 | 703 | 0.070 |
Why?
| | DNA, Viral | 1 | 2008 | 361 | 0.060 |
Why?
| | Radiosurgery | 1 | 2010 | 390 | 0.060 |
Why?
| | Occupational Exposure | 1 | 2010 | 352 | 0.060 |
Why?
| | Child | 3 | 2023 | 22493 | 0.060 |
Why?
| | Papillomavirus Vaccines | 1 | 2009 | 298 | 0.060 |
Why?
| | Sexual Behavior | 1 | 2009 | 490 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2097 | 0.050 |
Why?
| | Time Factors | 1 | 2016 | 7081 | 0.050 |
Why?
| | Health Services Accessibility | 2 | 2023 | 1086 | 0.050 |
Why?
| | Child, Preschool | 1 | 2019 | 11656 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1241 | 0.050 |
Why?
| | Pennsylvania | 1 | 2024 | 136 | 0.050 |
Why?
| | Quality of Life | 2 | 2013 | 3146 | 0.050 |
Why?
| | Firearms | 1 | 2010 | 423 | 0.050 |
Why?
| | Gray Matter | 1 | 2024 | 89 | 0.050 |
Why?
| | Organ Size | 1 | 2024 | 471 | 0.050 |
Why?
| | Cranial Sinuses | 1 | 2022 | 15 | 0.050 |
Why?
| | Career Mobility | 1 | 2023 | 70 | 0.050 |
Why?
| | Earache | 1 | 2022 | 6 | 0.050 |
Why?
| | Skull Base | 1 | 2022 | 53 | 0.050 |
Why?
| | Neck Pain | 1 | 2022 | 27 | 0.040 |
Why?
| | Constriction, Pathologic | 1 | 2022 | 246 | 0.040 |
Why?
| | Maryland | 1 | 2021 | 63 | 0.040 |
Why?
| | Inflammation | 1 | 2012 | 2900 | 0.040 |
Why?
| | Motion | 1 | 2021 | 100 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 2590 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1088 | 0.040 |
Why?
| | Telomere | 1 | 2023 | 286 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1858 | 0.040 |
Why?
| | Faculty, Medical | 1 | 2023 | 299 | 0.040 |
Why?
| | Schools | 1 | 2023 | 458 | 0.040 |
Why?
| | Acute Disease | 1 | 2022 | 999 | 0.040 |
Why?
| | Vestibular Neuronitis | 1 | 2018 | 2 | 0.040 |
Why?
| | Movement | 1 | 2021 | 295 | 0.040 |
Why?
| | Syncope | 1 | 2018 | 55 | 0.030 |
Why?
| | Medical History Taking | 1 | 2018 | 113 | 0.030 |
Why?
| | Physical Examination | 1 | 2018 | 235 | 0.030 |
Why?
| | Neurology | 1 | 2018 | 110 | 0.030 |
Why?
| | Acoustic Impedance Tests | 1 | 2016 | 13 | 0.030 |
Why?
| | Cotinine | 1 | 2016 | 79 | 0.030 |
Why?
| | Pressure | 1 | 2016 | 230 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2874 | 0.030 |
Why?
| | Cadaver | 1 | 2016 | 301 | 0.030 |
Why?
| | Patient Safety | 1 | 2018 | 338 | 0.030 |
Why?
| | Acceleration | 1 | 2014 | 34 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1682 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1986 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1503 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 865 | 0.030 |
Why?
| | Hospitalization | 1 | 2024 | 2346 | 0.030 |
Why?
| | Salivary Glands | 1 | 2012 | 35 | 0.020 |
Why?
| | Cues | 1 | 2015 | 325 | 0.020 |
Why?
| | Surgical Instruments | 1 | 2012 | 51 | 0.020 |
Why?
| | CpG Islands | 1 | 2012 | 167 | 0.020 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2012 | 69 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2268 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2012 | 84 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1902 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2012 | 457 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 516 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 871 | 0.020 |
Why?
| | Software | 1 | 2016 | 692 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 371 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 704 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 863 | 0.020 |
Why?
| | Homosexuality | 1 | 2009 | 17 | 0.020 |
Why?
| | Heterosexuality | 1 | 2009 | 43 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1266 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2011 | 538 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1463 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1309 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2012 | 1496 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2012 | 2541 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5327 | 0.010 |
Why?
| | Prognosis | 1 | 2011 | 4221 | 0.010 |
Why?
| | Animals | 1 | 2019 | 38231 | 0.010 |
Why?
|
|
Agrawal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|